Bvf II Gp LLC insider trades
Bvf II Gp LLC has filed 6 Form 4s with the SEC that we hold, for Cullinan Therapeutics, Inc. (CGEM) (10% owner), Kymera Therapeutics, Inc. (KYMR) (Director), Olema Pharmaceuticals, Inc. (OLMA) (Director, 10% owner) and RAIN (Director), among 5 companies in all. Across all of them we count 20 purchases worth $40.1M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 660,654 shares of RPTX worth $7.7M, dated 2022-06-02. The first filing on our record is dated 2022-04-05 and the latest 2024-06-18.
Cullinan Therapeutics, Inc. (CGEM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-01 | P, purchase reported on Form 4 | 9,402 | $101.1K | 2022-04-05 |
| 2022-04-01 | P, purchase reported on Form 4 | 266,598 | $2.9M | 2022-04-05 |
Kymera Therapeutics, Inc. (KYMR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-11-02 | P, purchase reported on Form 4 | 57,618 | $670.7K | 2023-11-06 |
| 2023-11-02 | P, purchase reported on Form 4 | 132,016 | $1.5M | 2023-11-06 |
| 2023-11-02 | P, purchase reported on Form 4 | 26,772 | $311.6K | 2023-11-06 |
| 2023-11-03 | P, purchase reported on Form 4 | 10,106 | $142.2K | 2023-11-06 |
| 2023-11-03 | P, purchase reported on Form 4 | 103,885 | $1.5M | 2023-11-06 |
| 2023-11-03 | P, purchase reported on Form 4 | 83,708 | $1.2M | 2023-11-06 |
Olema Pharmaceuticals, Inc. (OLMA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RAIN (RAIN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-08 | P, purchase reported on Form 4 | 685,330 | $4.0M | 2022-11-10 |
| 2022-11-08 | P, purchase reported on Form 4 | 54,857 | $319.8K | 2022-11-10 |
| 2022-11-08 | P, purchase reported on Form 4 | 970,171 | $5.7M | 2022-11-10 |
RPTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-02 | P, purchase reported on Form 4 | 61,156 | $714.3K | 2022-06-06 |
| 2022-06-02 | P, purchase reported on Form 4 | 660,654 | $7.7M | 2022-06-06 |
| 2022-06-02 | P, purchase reported on Form 4 | 464,235 | $5.4M | 2022-06-06 |
| 2022-06-03 | P, purchase reported on Form 4 | 31,903 | $392.1K | 2022-06-06 |
| 2022-06-03 | P, purchase reported on Form 4 | 353,344 | $4.3M | 2022-06-06 |
| 2022-06-03 | P, purchase reported on Form 4 | 258,797 | $3.2M | 2022-06-06 |
| 2022-06-06 | P, purchase reported on Form 4 | 3,809 | $50.3K | 2022-06-06 |
| 2022-06-06 | P, purchase reported on Form 4 | 20 | $264 | 2022-06-06 |
| 2022-06-06 | P, purchase reported on Form 4 | 3,040 | $40.2K | 2022-06-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1803806) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms